Effect of Magnesium Sulphate on Neostigmine
NCT03020706 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166
Last updated 2017-01-13
Summary
The purpose of this study is to evaluate the effect of magnesium sulphate on neostigmine-induced reversal of neuromuscular block by rocuronium
Conditions
- Neuromuscular Blockade
Interventions
- DRUG
-
Magnesium Sulfate, Injectable
magnesium sulphate intravenous administration during general anesthesia
Sponsors & Collaborators
-
Seoul National University Hospital
collaborator OTHER -
Gachon University Gil Medical Center
lead OTHER
Principal Investigators
-
Sang-Hwan Do, MD, Ph D · Seoul National University Bundang Hospital
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium
NCT01885715 ·Status: COMPLETED ·Phase: NA
-
Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients
NCT06228092 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Magnesium Citrate Supplementation in Restless Legs Syndrome (RLS)
NCT04462796 ·Status: UNKNOWN ·Phase: NA
-
The Early Reversibility of Rocuronium After Different Doses of Neostigmine
NCT00001520 ·Status: COMPLETED ·Phase: PHASE4
-
Reversal of Neuromuscular Blockade During the General Anaesthesia
NCT04048655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
NCT03346057 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Neuromuscular Blockade and Reversal on Breathing
NCT02845375 ·Status: COMPLETED ·Phase: PHASE4
-
Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial
NCT06136585 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)
NCT03346070 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium
NCT01782820 ·Status: COMPLETED
-
Neostigmine Reversal And Neuromuscular Recovery
NCT02433808 ·Status: COMPLETED ·Phase: PHASE4
-
Reversal of Neuromuscular Blockade in Thoracic Surgical Patients
NCT01837498 ·Status: COMPLETED
-
Sugammadex and Neostigmine at Shallow Neuromuscular Blockade
NCT00895609 ·Status: COMPLETED ·Phase: PHASE4
-
Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery
NCT03112993 ·Status: COMPLETED ·Phase: PHASE4
-
Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
NCT06745492 ·Status: COMPLETED
-
Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex
NCT02401841 ·Status: UNKNOWN
-
Efficacy and Safety of Nitrazine in the Treatment of ALS
NCT04950647 ·Status: UNKNOWN ·Phase: PHASE2
-
Electromyography in Patients on Chronic Pyridostigmine Therapy
NCT02364180 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3
NCT02227823 ·Status: COMPLETED ·Phase: PHASE2
-
Enteral Glutamine in Neurologically-injured Patients
NCT00204971 ·Status: COMPLETED ·Phase: PHASE4
-
Fade Upon TOF Stimulation Induced by Succinylcholine
NCT02425449 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans
NCT03754842 ·Status: COMPLETED ·Phase: NA
-
Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis
NCT03510546 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety Study of HPP593 in Subjects During and After Limb Immobilization
NCT01524406 ·Status: TERMINATED ·Phase: PHASE1
-
A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
NCT01549847 ·Status: WITHDRAWN ·Phase: PHASE3